Literature DB >> 33622929

Impact of Colon Cancer Location on the Prognostic Significance of Nutritional Indexes and Inflammatory Markers.

Tamuro Hayama1, Tsuyoshi Ozawa2, Kentaro Asako2, Rie Kondo2, Kohei Ono2, Yuka Okada2, Mitsuo Tsukamoto2, Yoshihisa Fukushima2, Ryu Shimada2, Keijiro Nozawa2, Keiji Matsuda2, Shoichi Fujii3, Takeo Fukagawa2, Yojiro Hashiguchi2.   

Abstract

BACKGROUND/AIM: The prognosis of colorectal cancer is reported to differ depending on the tumor site, and clinical differences depending on the site of occurrence have gained attention. The aim was to compare nutrition index and inflammatory markers according to the site of colon cancer. PATIENTS AND METHODS: We retrospectively analyzed 272 cases of stage I-III colon cancer (55% males, 45% females). The clinical characteristics, nutrition index and inflammatory markers were compared between patients with right colon cancer (RCC, n=119) and those with left colon cancer (LCC, n=153), and the relapse-free survival was then compared.
RESULTS: RCC was associated with older age (p=0.03), female gender (p=0.003), higher T stage (p=0.01), elevated platelet/lymphocyte ratio (PLR) (p=0.009), and elevated CONUT score (p=0.028). The prognostic values differed between RCC and LCC (RCC: CONUT score, p=0.04, LCC: PLR, p=0.02).
CONCLUSION: RCC was associated with an elevated CONUT score and PLR. In RCC, the CONUT score was an independent recurrence factor, and in LCC, the PLR was an independent recurrence factor. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CAR; CONUT score; NLR; PLR; colorectal cancer; mGPS

Year:  2021        PMID: 33622929      PMCID: PMC8045081          DOI: 10.21873/invivo.12377

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  24 in total

1.  Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.

Authors:  S Y Brulé; D J Jonker; C S Karapetis; C J O'Callaghan; M J Moore; R Wong; N C Tebbutt; Cr Underhill; D Yip; J R Zalcberg; D Tu; R A Goodwin
Journal:  Eur J Cancer       Date:  2015-05-12       Impact factor: 9.162

2.  Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon.

Authors:  Soichiro Ishihara; Toshiaki Watanabe; Takuya Akahane; Ryu Shimada; Atsushi Horiuchi; Hajime Shibuya; Tamuro Hayama; Hideki Yamada; Keijiro Nozawa; Keiji Matsuda; Koutarou Maeda; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2011-11-04       Impact factor: 2.571

3.  Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers.

Authors:  Tsuyoshi Ozawa; Yojiro Hashiguchi; Takahiro Yagi; Yoshihisa Fukushima; Ryu Shimada; Tamuro Hayama; Takeshi Tsuchiya; Keijiro Nozawa; Hisae Iinuma; Soichiro Ishihara; Keiji Matsuda
Journal:  Int J Colorectal Dis       Date:  2019-09-02       Impact factor: 2.571

4.  Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.

Authors:  Donald C McMillan; Joseph E M Crozier; Khalid Canna; Wilson J Angerson; Colin S McArdle
Journal:  Int J Colorectal Dis       Date:  2007-01-24       Impact factor: 2.571

5.  Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer.

Authors:  Joji Watanabe; Shinji Otani; Teruhisa Sakamoto; Yosuke Arai; Takehiko Hanaki; Masataka Amisaki; Naruo Tokuyasu; Soichiro Honjo; Masahide Ikeguchi
Journal:  Surg Today       Date:  2016-02-11       Impact factor: 2.549

6.  Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Authors:  Makito Miyake; Yosuke Morizawa; Shunta Hori; Nagaaki Marugami; Kota Iida; Kenta Ohnishi; Daisuke Gotoh; Yoshihiro Tatsumi; Yasushi Nakai; Takeshi Inoue; Satoshi Anai; Kazumasa Torimoto; Katsuya Aoki; Nobumichi Tanaka; Keiji Shimada; Noboru Konishi; Kiyohide Fujimoto
Journal:  Oncology       Date:  2017-06-24       Impact factor: 2.935

Review 7.  Platelet-cancer interactions.

Authors:  Hadi A Goubran; Julie Stakiw; Mirjana Radosevic; Thierry Burnouf
Journal:  Semin Thromb Hemost       Date:  2014-03-03       Impact factor: 4.180

Review 8.  Platelets in cancer and thrombosis.

Authors:  J Riedl; I Pabinger; C Ay
Journal:  Hamostaseologie       Date:  2013-12-05       Impact factor: 1.778

9.  Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer.

Authors:  Corrado Pedrazzani; Guido Mantovani; Eduardo Fernandes; Fabio Bagante; Gian Luca Salvagno; Niccolò Surci; Tommaso Campagnaro; Andrea Ruzzenente; Elisa Danese; Giuseppe Lippi; Alfredo Guglielmi
Journal:  Sci Rep       Date:  2017-05-04       Impact factor: 4.379

10.  Differences in oncological outcomes and inflammatory biomarkers between right-sided and left-sided stage I-III colorectal adenocarcinoma.

Authors:  Dongming Guo; Xinxin Li; Aosi Xie; Qiangjian Cao; Jinhai Zhang; Feiran Zhang; Wei Li; Juntian Chen
Journal:  J Clin Lab Anal       Date:  2019-11-21       Impact factor: 2.352

View more
  3 in total

1.  Neutrophil-to-Lymphocyte Ratio as an Indicator of Opioid-Induced Immunosuppression After Thoracoscopic Surgery: A Randomized Controlled Trial.

Authors:  Qi Chen; Jingqiu Liang; Ling Liang; Zhongli Liao; Bin Yang; Jun Qi
Journal:  J Pain Res       Date:  2022-06-30       Impact factor: 2.832

2.  Blood-Cell-Based Inflammatory Markers as a Useful Tool for Early Diagnosis in Colorectal Cancer.

Authors:  Maria Hernandez-Ainsa; Raul Velamazan; Angel Lanas; Patricia Carrera-Lasfuentes; Elena Piazuelo
Journal:  Front Med (Lausanne)       Date:  2022-06-20

3.  The preoperative geriatric nutritional risk index (GNRI) is an independent prognostic factor in elderly patients underwent curative resection for colorectal cancer.

Authors:  Tamuro Hayama; Yojiro Hashiguchi; Tsuyoshi Ozawa; Makoto Watanabe; Yoshihisa Fukushima; Ryu Shimada; Keijiro Nozawa; Keiji Matsuda; Shoichi Fujii; Takeo Fukagawa
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.